Market Cap 22.68M
Revenue (ttm) 570,000.00
Net Income (ttm) -26.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,645.61%
Debt to Equity Ratio 0.00
Volume 520,100
Avg Vol 179,626
Day's Range N/A - N/A
Shares Out 33.35M
Stochastic %K 79%
Beta 2.00
Analysts Sell
Price Target $2.00

Company Profile

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET i...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 775 7936
Address:
P.O. BOX 125, Stewartsville, United States
hiTHit
hiTHit Jul. 2 at 6:03 PM
$VYNE The CEO tells the shareholders: "I don't recall promising you that the share price would go up. Now I'm telling you that the price isn't going to go up, and if you aren't happy about it, sell your holdings immediately and get the hell out of here."
1 · Reply
Dimitri_Prints
Dimitri_Prints Jun. 28 at 12:25 PM
$VYNE getting it for the low tomorrow
0 · Reply
NewMoonHarvest
NewMoonHarvest Jun. 24 at 6:42 PM
$VYNE I'll hold for a bigger write off.
3 · Reply
Rulaxx1574
Rulaxx1574 Jun. 12 at 4:30 PM
$VYNE corrupt CEO. Pocketed the cash.
1 · Reply
hiTHit
hiTHit Jun. 9 at 5:31 PM
$VYNE If everyone here says the price is going to go up, at least one person is lying.
1 · Reply
SuperGreenToday
SuperGreenToday Jun. 5 at 6:30 PM
0 · Reply
hiTHit
hiTHit Jun. 4 at 5:59 PM
$VYNE 1+0=10, we weren't mistaken because we already knew it would mislead us.
1 · Reply
FoolishSpeculator
FoolishSpeculator Jun. 2 at 12:21 PM
$VYNE This is my last warning here, don't buy this shit. I'm selling out at -99% for tax purposes. Buy actual companies with actual earnings, no fairy-tales.
1 · Reply
focafoca99
focafoca99 May. 21 at 9:30 PM
$VYNE released an investor presentation related to its proposed transaction with Yarrow.
0 · Reply
bcbholdem
bcbholdem May. 12 at 5:41 PM
$VYNE EVER
2 · Reply
Latest News on VYNE
VYNE Therapeutics Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 7 weeks ago

VYNE Therapeutics Quarterly report: Q1 2026


VYNE Therapeutics Annual report: Q4 2025

Feb 27, 2026, 7:00 AM EST - 4 months ago

VYNE Therapeutics Annual report: Q4 2025


VYNE Therapeutics Transcript: M&A Announcement

Dec 17, 2025, 8:30 AM EST - 7 months ago

VYNE Therapeutics Transcript: M&A Announcement


VYNE Therapeutics Press release: M&A Announcement

Dec 17, 2025, 8:30 AM EST - 7 months ago

VYNE Therapeutics Press release: M&A Announcement


VYNE Therapeutics, Yarrow Bioscience enter merger agreement

2025-12-17T13:05:35.000Z - 7 months ago

VYNE Therapeutics, Yarrow Bioscience enter merger agreement


VYNE Therapeutics Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 8 months ago

VYNE Therapeutics Proxy statement: Proxy Filing


VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year

2025-11-06T13:11:20.000Z - 8 months ago

VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year


VYNE Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

VYNE Therapeutics Quarterly report: Q3 2025


VYNE Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

VYNE Therapeutics Earnings release: Q3 2025


VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year

2025-08-14T12:05:20.000Z - 11 months ago

VYNE Therapeutics reports Q2 EPS (13c) vs (22c) last year


VYNE Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

VYNE Therapeutics Quarterly report: Q2 2025


VYNE Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

VYNE Therapeutics Earnings release: Q2 2025


Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?

2025-07-31T00:36:00.000Z - 1 year ago

Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?


VYNE Therapeutics downgraded to Neutral from Buy at BTIG

2025-07-30T23:45:15.000Z - 1 year ago

VYNE Therapeutics downgraded to Neutral from Buy at BTIG


VYNE Therapeutics reports Q1 EPS (20c) vs (15c) last year

2025-05-08T12:40:54.000Z - 1 year ago

VYNE Therapeutics reports Q1 EPS (20c) vs (15c) last year


VYNE Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

VYNE Therapeutics Quarterly report: Q1 2025


VYNE Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

VYNE Therapeutics Earnings release: Q1 2025


VYNE Therapeutics Provides Update on VYN202 Program

Apr 25, 2025, 8:00 AM EDT - 1 year ago

VYNE Therapeutics Provides Update on VYN202 Program


VYNE Therapeutics reports Q4 EPS (28c) vs (20c) last year

2025-03-06T13:06:55.000Z - 1 year ago

VYNE Therapeutics reports Q4 EPS (28c) vs (20c) last year


VYNE Therapeutics Annual report: Q4 2024

Mar 6, 2025, 7:00 AM EST - 1 year ago

VYNE Therapeutics Annual report: Q4 2024


VYNE Therapeutics Earnings release: Q4 2024

Mar 6, 2025, 7:00 AM EST - 1 year ago

VYNE Therapeutics Earnings release: Q4 2024


VYNE Therapeutics Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

VYNE Therapeutics Proxy statement: Proxy Filing


VYNE Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

VYNE Therapeutics Quarterly report: Q3 2024


VYNE Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

VYNE Therapeutics Earnings release: Q3 2024


VYNE Therapeutics Quarterly report: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 2 years ago

VYNE Therapeutics Quarterly report: Q2 2024


VYNE Therapeutics Earnings release: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 2 years ago

VYNE Therapeutics Earnings release: Q2 2024


VYNE Therapeutics Quarterly report: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

VYNE Therapeutics Quarterly report: Q1 2024


VYNE Therapeutics Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

VYNE Therapeutics Earnings release: Q1 2024


VYNE Therapeutics Registration statement: Registration Filing

Mar 1, 2024, 7:00 AM EST - 2 years ago

VYNE Therapeutics Registration statement: Registration Filing


VYNE Therapeutics Annual report: Q4 2023

Feb 29, 2024, 7:00 AM EST - 2 years ago

VYNE Therapeutics Annual report: Q4 2023


VYNE Therapeutics Earnings release: Q4 2023

Feb 29, 2024, 7:00 AM EST - 2 years ago

VYNE Therapeutics Earnings release: Q4 2023


Menlo Ventures Raises $1.35B for AI Investments

Nov 16, 2023, 4:03 PM EST - 2 years ago

Menlo Ventures Raises $1.35B for AI Investments


VYNE Therapeutics Quarterly report: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

VYNE Therapeutics Quarterly report: Q3 2023


VYNE Therapeutics Earnings release: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

VYNE Therapeutics Earnings release: Q3 2023


VYNE Therapeutics Registration statement: Registration Filing

Nov 13, 2023, 7:00 AM EST - 2 years ago

VYNE Therapeutics Registration statement: Registration Filing


VYNE Therapeutics Proxy statement: Proxy Filing

Nov 13, 2023, 7:00 AM EST - 2 years ago

VYNE Therapeutics Proxy statement: Proxy Filing


VYNE Therapeutics Transcript: R&D Day 2023

Nov 9, 2023, 1:30 PM EST - 2 years ago

VYNE Therapeutics Transcript: R&D Day 2023


VYNE Therapeutics Slides: FY 2023

Nov 9, 2023, 1:30 PM EST - 2 years ago

VYNE Therapeutics Slides: FY 2023


VYNE Therapeutics Announces Private Placement of $88 Million

Oct 30, 2023, 7:05 AM EDT - 2 years ago

VYNE Therapeutics Announces Private Placement of $88 Million


VYNE Therapeutics Quarterly report: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

VYNE Therapeutics Quarterly report: Q2 2023


VYNE Therapeutics Earnings release: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

VYNE Therapeutics Earnings release: Q2 2023


VYNE Therapeutics to Attend BIO International Convention

May 18, 2023, 8:00 AM EDT - 3 years ago

VYNE Therapeutics to Attend BIO International Convention


VYNE Therapeutics Quarterly report: Q1 2023

May 11, 2023, 7:00 AM EDT - 3 years ago

VYNE Therapeutics Quarterly report: Q1 2023


VYNE Therapeutics Earnings release: Q1 2023

May 11, 2023, 7:00 AM EDT - 3 years ago

VYNE Therapeutics Earnings release: Q1 2023


VYNE Therapeutics Annual report: Q4 2022

Mar 9, 2023, 7:00 AM EST - 3 years ago

VYNE Therapeutics Annual report: Q4 2022


VYNE Therapeutics Earnings release: Q4 2022

Mar 9, 2023, 7:00 AM EST - 3 years ago

VYNE Therapeutics Earnings release: Q4 2022


VYNE Therapeutics Announces Reverse Stock Split

Feb 10, 2023, 8:00 AM EST - 3 years ago

VYNE Therapeutics Announces Reverse Stock Split


hiTHit
hiTHit Jul. 2 at 6:03 PM
$VYNE The CEO tells the shareholders: "I don't recall promising you that the share price would go up. Now I'm telling you that the price isn't going to go up, and if you aren't happy about it, sell your holdings immediately and get the hell out of here."
1 · Reply
Dimitri_Prints
Dimitri_Prints Jun. 28 at 12:25 PM
$VYNE getting it for the low tomorrow
0 · Reply
NewMoonHarvest
NewMoonHarvest Jun. 24 at 6:42 PM
$VYNE I'll hold for a bigger write off.
3 · Reply
Rulaxx1574
Rulaxx1574 Jun. 12 at 4:30 PM
$VYNE corrupt CEO. Pocketed the cash.
1 · Reply
hiTHit
hiTHit Jun. 9 at 5:31 PM
$VYNE If everyone here says the price is going to go up, at least one person is lying.
1 · Reply
SuperGreenToday
SuperGreenToday Jun. 5 at 6:30 PM
0 · Reply
hiTHit
hiTHit Jun. 4 at 5:59 PM
$VYNE 1+0=10, we weren't mistaken because we already knew it would mislead us.
1 · Reply
FoolishSpeculator
FoolishSpeculator Jun. 2 at 12:21 PM
$VYNE This is my last warning here, don't buy this shit. I'm selling out at -99% for tax purposes. Buy actual companies with actual earnings, no fairy-tales.
1 · Reply
focafoca99
focafoca99 May. 21 at 9:30 PM
$VYNE released an investor presentation related to its proposed transaction with Yarrow.
0 · Reply
bcbholdem
bcbholdem May. 12 at 5:41 PM
$VYNE EVER
2 · Reply
DarvasBoxing
DarvasBoxing May. 5 at 1:54 PM
$VYNE any news?
3 · Reply
hiTHit
hiTHit Apr. 27 at 6:50 PM
$VYNE I’m not asking for your opinion, but as time goes on, I’m becoming increasingly convinced that I’ve been scammed. Where did all that money go?
1 · Reply
Deepsea1
Deepsea1 Apr. 20 at 7:32 PM
$VYNE broke .63 resistance on heavy volume. Move higher coming!
1 · Reply
hiTHit
hiTHit Apr. 15 at 4:51 PM
$VYNE Today will be a happy day for us. Whether you believe me or not, I don't expect the price to go up today either. We've been in a coma for 5 years and we're tired of laughing at ourselves.
1 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 13 at 8:14 PM
$PCSA I still maintain this is less about data and more likely a RM play, whether it be a crypto treasury RM w/ Dreyfus or some other company. I think the data continually being delayed is very telling that the company is not planning on continuing on their own. Just my opinion. $BRNS $VYNE and $RLYB all are recent examples of companies who had upcoming data but all ended up doing RM's instead.
2 · Reply
hiTHit
hiTHit Apr. 13 at 5:29 PM
$VYNE Our eye retina has been placed upside down due to an evolutionary error. But our brain instantly corrects these distorted images. But since I do not have a brain, I still see the price of VYNE as $0.60
0 · Reply
Stock__Hunter
Stock__Hunter Apr. 9 at 2:39 PM
$VYNE as long she holds 50ma
0 · Reply
Stock__Hunter
Stock__Hunter Apr. 8 at 12:33 PM
$VYNE some get on the horn with ceo..needs a kick... .60=zzzzzzzz wake me up
0 · Reply
hiTHit
hiTHit Apr. 1 at 4:24 PM
$VYNE Today, April 1, I promise you that there will be no RS in the future.
2 · Reply
hiTHit
hiTHit Mar. 31 at 3:32 PM
$VYNE I was elected as the president of the Smart Investors Association that buys shares of companies that have made RS.🤓
0 · Reply
Stock__Hunter
Stock__Hunter Mar. 30 at 4:53 PM
$VYNE Today was the start of the down turn.. but 95% of all stocks are in same boat
0 · Reply